Skip to main content

Open Access 20.03.2024 | Original Paper

Deciphering the interplay between psychopathological symptoms, sensorimotor, cognitive and global functioning: a transdiagnostic network analysis

verfasst von: Stefan Fritze, Geva A. Brandt, Sebastian Volkmer, Jonas Daub, Maria Krayem, Jacqueline Kukovic, Emanuel Schwarz, Urs Braun, Georg Northoff, Robert Christian Wolf, Katharina M. Kubera, Andreas Meyer-Lindenberg, Dusan Hirjak

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience

Abstract

Background

Understanding the relationship between psychopathology and major domains of human neurobehavioral functioning may identify new transdiagnostic treatment targets. However, studies examining the interrelationship between psychopathological symptoms, sensorimotor, cognitive, and global functioning in a transdiagnostic sample are lacking. We hypothesized a close relationship between sensorimotor and cognitive functioning in a transdiagnostic patient sample.

Methods

We applied network analysis and community detection methods to examine the interplay and centrality [expected influence (EI) and strength] between psychopathological symptoms, sensorimotor, cognitive, and global functioning in a transdiagnostic sample consisting of 174 schizophrenia spectrum (SSD) and 38 mood disorder (MOD) patients. All patients (n = 212) were examined with the Positive and Negative Syndrome Scale (PANSS), the Heidelberg Neurological Soft Signs Scale (NSS), the Global Assessment of Functioning (GAF), and the Brief Cognitive Assessment Tool for Schizophrenia consisted of trail making test B (TMT-B), category fluency (CF) and digit symbol substitution test (DSST).

Results

NSS showed closer connections with TMT-B, CF, and DSST than with GAF and PANSS. DSST, PANSS general, and NSS motor coordination scores showed the highest EI. Sensory integration, DSST, and CF showed the highest strength.

Conclusions

The close connection between sensorimotor and cognitive impairment as well as the high centrality of sensorimotor symptoms suggests that both domains share aspects of SSD and MOD pathophysiology. But, because the majority of the study population was diagnosed with SSD, the question as to whether sensorimotor symptoms are really a transdiagnostic therapeutic target needs to be examined in future studies including more balanced diagnostic groups.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s00406-024-01782-3.

Introduction

The co-occurrence of psychopathological symptoms stemming from different functional domains is characteristic of psychiatric disorders. For instance, schizophrenia spectrum disorders (SSD) are characterized by psychopathological symptoms from various functional domains, including sensory–perceptual (e.g., hallucinations), cognitive (e.g., delusions, impaired working memory and executive functioning), affective (e.g., flat affect, anhedonia and depressive symptomatology [1]), somatic (e.g., fatigue, muscle pain, gastrointestinal symptoms and tension [2]), social (e.g., social isolation and autism), and sensorimotor (e.g., rigor, tremor, psychomotor slowing and akinesia [3]), respectively. In mood disorders (MOD), such as major depressive disorder (MDD) and bipolar disorder (BD), patients not only experience low mood, sadness [4], low self-esteem, lack of drive, and loss of interest or pleasure but also co-occurring cognitive changes (e.g., rumination [5] and impaired working memory [6]), somatic-neurovegetative (chest pain, gastrointestinal symptoms, irritable bowel, or other [7]), interpersonal (e.g., social anxiety and withdrawal [8]), sensory–perceptual (aberrant visual perception [9]), and motor (psychomotor retardation or agitation [10]) symptoms.
Furthermore, the majority of the psychopathological symptoms mentioned above are core diagnostic criteria for SSD and MOD by the most widely used diagnostic systems in clinical practice, such as the DSM-5 and ICD-11. The overlap and co-occurrence of psychopathological symptoms in SSD and MOD are specifically mentioned in both diagnostic systems as the foundation for differential diagnostic considerations. However, their intrinsic relationships—that is, in what ways do the various psychopathological symptoms interact and which symptoms are central or influential across SSD and MOD—remain understudied. In the last few years, novel statistical methods have been developed to explore the interplay between psychopathological symptoms and global functioning in psychiatric disorders [1113]. In particular, network analysis can help identifying which psychopathological symptoms are central or influential within a network of different clinical variables [14, 15]. Central psychopathological symptoms are those that have strong connections to other symptoms or clinical variables and may play a crucial role in the development and maintenance of the disorder. Therefore, network analysis is a promising method to investigate the complexity of interactions between psychopathological symptoms stemming from different functional domains across different psychiatric disorders. Instead of seeing psychopathological symptoms as standalone entities, network analysis conceives of them as components of a complex network that interact with one another and frequently reinforce one another. In line with this, psychiatric disorders, such as SSD and MOD, might arise from the direct interactions of symptoms within a network architecture.
In the last two years, the network analysis method has contributed to a considerable increase in knowledge in the field of different psychopathological symptoms [1618]. However, the studies using network analysis method have investigated mainly the interaction between different categories of psychopathological symptoms using single items stemming from different rating scales such as the Brief Negative Symptom Scale (BNSS) or the Positive and Negative Syndrome Scale (PANSS) in uni-diagnostic psychiatric samples [1618].
Based on the recent evidence that distinct Neurological Soft Signs (NSS) have been shown to be differentially associated with psychopathology as well as cognition in SSD [1921] and BD [22], the main goal of this study was to examine the associations among psychopathological symptoms, sensorimotor, cognitive, and global functioning in a transdiagnostic patient sample. We hypothesized that sensorimotor dysfunction, as examined with the Heidelberg NSS scale [23] would be more closely connected with cognition (as assessed with the Brief Cognitive Assessment Tool for Schizophrenia [B-CATS] [24]) than psychopathological symptoms examined with PANSS. Further, we hypothesized that sensorimotor dysfunction would be a central network component (as assessed with expected influence [EI] and strength). Unlike previous studies that conducted the network analyses at the single-item level, and because we had a strong prior theory on how variables are related, we decided to use subscale scores in order to examine associations between subdomains. If we confirmed our hypotheses, this study could point toward shared domain-based aspects of pathophysiology in SSD and MOD. This could point toward new treatment options for cognition, e.g., with stimulation techniques in specific brain regions associated with sensorimotor dysfunction [25, 26] or virtual reality [27].

Methods

Study participants

In this study, we combined two independent cohorts of patients from different studies conducted at the Central Institute of Mental Health (CIMH).
Cohort #1 consisted of 129 subjects fulfilling the DSM-IV-TR [28] criteria for schizophrenia spectrum disorders (SSD) and 7 subjects fulfilling the DSM-IV-TR [28] criteria for bipolar disorders (BD) [29, 30]. This cohort has been used in previous studies of our group [3, 31, 32]. Diagnoses were made by staff psychiatrists and confirmed using the German versions of the Structured Clinical Interview for DSM-IV-TR axis I and II disorders (SCID) and examination of the case notes (SF and DH).
Cohort #2 consisted of 76 subjects fulfilling the German Mini Diagnostic Interview for Mental Disorders (Mini-DIPS) [33] criteria for SSD (n = 45), major depressive disorder (MDD, n = 26) or BD (n = 5). Diagnoses were made by staff psychiatrists and confirmed using the examination of the case notes (SF, GAB and DH).
Patients in both cohorts were excluded if: (i) they were aged < 18 or > 65 years; (ii) they had a history of brain trauma or neurological disease (especially movement disorders); (iii) they had shown alcohol/substance use disorder within 12 months prior to participation.
The local Ethics Committees I and II (Medical Faculty Heidelberg and Medical Faculty Mannheim at Heidelberg University, Germany) approved the studies. We obtained written informed consent from all study participants after all aims and procedures of the study had been fully explained.

Clinical assessment

Patients in both cohorts were examined during in- or outpatient treatment after partial remission of acute psychopathological symptoms. All relevant study procedures (e.g., psychopathological rating scales, neuropsychological assessments and sensorimotor assessment) were completed within 7 days. All SSD and MOD patients were on a stable daily dose of antipsychotic, antidepressant or mood-stabilizing medication for at least 7 days. Antipsychotic and antidepressant medication was standardized as Olanzapine [OLZe] [34] and fluoxetine [FLX] [35] equivalents (s. Table 1 for details). OLZe and FLXe were z-transformed, summed up and included as covariates (medication) in subsequent analyses (see below).
Table 1
Clinical and demographic variables of study participants (n = 212)
Variable
Mean ± SD
Skewness
Kurtosis
Age
37.88 ± 12.22
Sex (m/f)
104/108
Education (years)
13.28 ± 2.87
OLZe
14.39 ± 11.31
0.59
2.91
FLXe
7.84 ± 18.44
2.28
7.04
PANSS positive
14.32 ± 6.47
1.11
4.10
PANSS negative
16.87 ± 7.33
0.64
2.56
PANSS general
33.91 ± 9.91
0.93
4.68
PANSS total score
65.10 ± 19.74
0.66
3.30
NSS MOCO
7.07 ± 4.01
0.62
3.05
NSS SI
3.32 ± 1.79
0.71
4.26
NSS COMT
3.32 ± 2.26
0.63
3.00
NSS RLSPO
2.84 ± 2.39
1.51
6.75
NSS HS
3.23 ± 1.91
0.24
2.59
NSS total score
19.78 ± 8.63
0.88
3.41
GAF*
54.29 ± 16.84
0.07
2.35
CF*
35.41 ± 18.70
-0.02
1.62
DSST*
47.30 ± 22.22
0.11
2.28
TMT-B (seconds)
107.25 ± 61.48
1.62
5.61
Data are mean ± standard deviation
SD standard deviation, m male, f female, OLZe Olanzapine equivalents, FLX fluoxetine equivalents, PANSS positive and negative syndrome scale, NSS neurological soft signs, MOCO motor coordination, SI sensory integration, RLSPO right/left spatial orientation, HS hard signs, CF category fluency, DSST digit symbol substitution test, TMT-B trail making test part B
*GAF, CF, and DSST are reverse coded values
Patients were examined with the PANSS [36] for psychopathological assessment, including the following PANSS subscores: positive, negative and general. The Heidelberg NSS scale [23] including its sub-scores motor coordination (MOCO), sensory integration (SI), hard signs (HS), complex motor tasks (COMT), right/left spatial orientation (RLSPO) was used for sensorimotor assessment. General functioning was assessed with the Global Assessment of Functioning (GAF) scale [37]. Cognitive functioning was assessed with B-CATS [24], which consisted of trail making test B (TMT-B), category fluency (CF), and digit symbol substitution test (DSST). One of the main prerequisites for this study was to obtain the largest possible sample with overlapping psychopathological, sensorimotor, cognitive, and global assessments. Therefore, we opted for scales/assessments that are feasible and map the four domains we were interested in. Further, we decided on scales/assessments that have been previously used in the three disorders [3840]. Therefore, PANSS, NSS, B-CATS, and GAF seemed to us to be the most suitable. Finally, we believe that the included scales PANSS, NSS, B-CATS, and GAF also allow good comparability with other studies.

Statistical analyses

We used R version 4.0.4 and Rstudio version 1.3.1093 [41]. Initially, a descriptive analysis of demographic and clinical data was performed. Then, the homogeneity of variances and the normality of PANSS, NSS, GAF, and B-CATS were investigated using Levene’s test and Shapiro–Wilk. Further analyses were performed with PANSS sub-scores (positive, negative, and general), NSS sub-scores (MOCO, HS, COMT, RLSPO, SI), GAF score, and B-CATS sub-scores (TMT-B, DSST, CF). We used sub-scores in order to examine differential associations between subdomains rather than broad global scores which may mask associations. Since higher values of the variables GAF, CF, and DSST indicated better performance (while on the remaining scales, higher values indicated worse performance), GAF, CF, and DSST were converted reversely.
Using these scores, we have carried out the following statistical analyses: First, in line with previously published studies [14, 4244], potentially relevant covariates (regression variables), such as age, sex, education, and medication, were not included in our analyses. Second, for completeness, we (A) regressed out age, sex, education, and medication and employed the residuals of PANSS sub-scores, NSS subscale scores, B-CATS sub-scores, and GAF score for network estimation and (B) included age, sex, education, and medication nodes in the network analyses (NA2-A and NA2-B) and EGA.
In the first and second step, we employed network analysis methods [45, 46]. In this approach, nodes represent variables, and lines between variables are termed edges, representing relationships to be investigated. The most common psychological network estimation technique uses partial correlations between variables (nodes), which are calculated after accounting for all other variable correlations. Blue edges refer to positive correlations, while red edges refer to negative correlations. Thicker edges refer to stronger correlations, while thinner edges refer to weaker correlations. Due to the violation of normality in our variables, we used a non-paranormal transformation in preparing the data. Employing the qgraph package, we set the default option of the estimateNetwork function to “huge”. Network estimation involved a graphical Gaussian model (GGM) [45, 47]. We applied the extended Bayesian information criterion (EBIC) [47, 48]. To avoid false-positive relationships between nodes, we regularized the network with the least absolute shrinkage and selection operator (LASSO) [47, 48]. LASSO can shrink small edges toward zero. Fruchterman–Reingold algorithm was used for visualization [48]. This algorithm places nodes with stronger correlations more centrally. To assess centrality, expected influence (EI) and strength were calculated. EI of a node represents the sum of all partial correlations (accounting for negative edges) and indicates its importance within a network graph. Higher values indicate stronger interconnectedness. Strength is the sum of absolute edge weights. To examine EI and strength stability, we employed a bootstrap approach with the bootnet package. Furthermore, and in order to investigate whether our results may have been driven by diagnosis, we repeated the network analyses including only SSD participants (n = 174, s. Supplementary Figs. 6–12). We refrained from repeating the analyses including only MOD patients (BD: n = 12; MDD: n = 24) or analyzing the two study cohorts (NSS cohort: n = 129; whiteCAT cohort: n = 83) separately, due to the small number of participants in terms of network analysis.
Then, in order to employ community detection methods on PANSS, NSS, GAF, and B-CATS, we used exploratory graph analysis (EGA) [4951]. To this end, we employed the EGAnet package. EGA calculates polychoric correlations with the walktrap algorithm in order to identify communities of the partial correlation matrix [49]. The walktrap algorithm calculates similarities between vertices hinged on random walks [49]. Additionally, item stability was evaluated with 1000 bootstrapped samples, assessing the proportion of times specific items clustered with their community. Network loadings for each community were investigated with EGAnet. Loadings are interpreted as the node´s expected influence on each community. Higher loadings indicate that a node has a higher influence on the occurrence of a community.
Third, to validate the results of the network analyses, a partial correlation (C) was run to determine the relationship between PANSS positive, negative and general score, NSS subscale scores, B-CATS subscores, and GAF score while controlling for age, sex, education, and medication.

Results

Clinical and demographic characteristics

The study cohort (n = 212) consisted of participants with SSD (n = 174), MDD (n = 26) and BD (n = 12). Mean age and education were 37.88 years and 13.28 years, respectively. There were 104 male and 108 female participants. Detailed demographic and clinical characteristics of participants across all diagnoses and the included variables as well as skewness and kurtosis for each variable are shown in Table 1 (for group differences between variables see Supplementary Table 1).

Network analysis

First, the network included the NSS, the PANSS, and the B-CATS sub-scores and GAF total scores (Fig. 1). Edges as well as expected influence (EI) and strength were deemed stable (s. Supplementary Figs. 1 and 2). The scores of the five NSS subscales showed low to no association with PANSS positive, negative, and general scores (Fig. 1, Table 2). MOCO showed associations with the three B-CATS sub-scores (Fig. 1, Table 2). SI showed an inverse association with CF and a positive association with TMT-B (Fig. 1, Table 2). The remaining NSS sub-scores showed fewer associations with B-CATS sub-scores (Fig. 1, Table 2). GAF was associated with PANSS scores and NSS IF sub-scores (Fig. 1, Table 2). DSST, PANSS general, MOCO, and TMT-B showed the largest EI as a measure of centrality (Fig. 2). EI of MOCO was not significantly different from DSST, PANSS general, or TMT-B EI (s. Supplementary Fig. 3), indicating similar centrality. Also, SI, DSST, and CF showed the highest strength as another measure of centrality, followed by PANSS general and MOCO (Fig. 2). SI strength was not significantly different from strength of either DSST, CF, PANSS general, MOCO, or TMT-B, indicating similar centrality (s. Supplementary Fig. 3).
Table 2
Partial correlation matrix
 
PANSS positive
PANSS negative
PANSS general
NSS MOCO
NSS SI
NSS COMT
NSS RLSPO
NSS HS
GAF
CF
DSST
TMT-B
PANSS positive
0
0
0.470
0.032
0
− 0.034
0.010
0
0.080
0.038
0
0.012
PANSS negative
0
0
0.368
0
0.076
0.019
0.009
0.009
0.258
0.054
0
0
PANSS general
0.470
0.368
0
0
0
0
0
0
0.186
0
0.055
0
NSS MOCO
0.032
0
0
0
0.180
0.187
0.161
0
0
0.193
0.097
0.163
NSS SI
0
0.076
0
0.180
0
0
0.133
0.242
0.134
0.288
0.050
0.216
NSS COMT
0.034
0.019
0
0.187
0
0
0.201
0.142
0.050
0
0.117
0.086
NSS RLSPO
0.010
0.009
0
0.161
0.133
0.201
0
0
0.022
0.007
0.013
0.022
NSS HS
0
0.009
0
0
0.242
0.142
0
0
0.004
0.020
0
0
GAF
0.080
0.258
0.186
0
0.135
0.050
0.022
0.004
0
− 0.017
0
0.003
CF
0.038
0.054
0
0.193
− 0.288
0
0.007
0.020
− 0.017
0
0.469
0.022
DSST
0
0
0.055
0.097
− 0.050
0.117
0.013
0
0
0.469
0
0.441
TMT-B
0.012
0
0
0.163
0.216
0.086
0.022
0
0.003
0.022
0.441
0
Partial correlations between variables in our study sample (n = 212). Higher values indicate stronger associations between variables. Connections between NSS (particularly MOCO and SI) are stronger with cognition than with psychopathology
PANSS positive and negative symptoms scale, NSS neurological soft signs, MOCO motor coordination, SI sensory integration, RLSPO right/left spatial orientation, HS hard signs, CF category fluency, DSST digit symbol substitution test, TMT-B trail making test part B
*GAF, CF, and DSST are reverse coded values
Second, the network (NA2-A) estimated after regressing out age, sex, education, and medication was unstable and thus could not be interpreted and the results are not shown. Unstable in this context refers to low probability of being able to reproduce the estimated network structure, including edges. Further, the network analysis (NA2-B) including age, sex, education, and medication as additional nodes was sufficiently stable (s. Supplementary Figs. 15 and 16) and the results remained comparable to our network analysis without these four variables (NA1): NSS still showed closer connections with TMT-B, CF and DSST than with GAF and PANSS (s. Supplementary Fig. 13 and supplementary Table 2). PANSS general, DSST, TMT, and NSS MOCO scores showed the highest EI, while DSST, SI, and TMT showed the highest strength (s. Supplementary Fig. 14). Overall, age, sex, education, and medication showed low centrality (s. Supplementary Fig. 14).

Community detection

Bootstrapped EGA revealed three communities (Fig. 3): cluster #1 included GAF total score and the three PANSS subscores, cluster #2 included five NSS subscores, cluster #3 included TMT-B, DSST and CF. Item replicability was sufficient in cluster #1 and #2, yet there was low replicability in cluster #3 (Table 3). Bootstrapping dimension frequency was 0.57 for two factors and 0.39 for three factors, the median dimension was 2, and the confidence interval was 0.85–3.15. Network loadings are shown in Table 4. In total, the EGA results were deemed unstable and therefore, we refrained from repeating the EGA including age, sex, education, and medication.
Table 3
Item replicability corresponding to the exploratory graph analysis (EGA) community structure
 
Communitya
1
2
3
COMT
0.96
RLSPO
0.96
MOCO
0.90
0.10
HS
0.93
SI
0.87
0.11
PANSS-P
1.00
PANSS-G
1.00
PANSS-N
1.00
GAF
1.00
CF
0.61
0.40
DSST
0.61
0.39
TMT-B
0.64
0.36
PANSS positive and negative syndrome scale (P positive, G general, N negative), GAF global assessment of functioning, NSS neurological soft signs, COMT complex motor tasks, MOCO motor coordination, SI sensory integration, RLSPO right/left spatial orientation, HS hard signs, CF category fluency, DSST digit symbol substitution test, TMT-B trail making test part B
aValues depict the proportion of times which an item formed part of the community in the bootstrapped EGA samples
Table 4
Network loadings corresponding to the Exploratory Graph Analysis (EGA) Community Structure
Clinical variable
Communitya
 
1
2
3
COMT
0.25
0.03
0.10
RLSPO
0.20
0.03
0.06
MOCO
0.34
0.03
0.25
HS
0.15
0.02
0.03
SI
0.31
0.09
0.19
PANSS-P
0.02
0.32
0.02
PANSS-G
0.02
0.55
0.03
PANSS-N
0.04
0.34
0.02
GAF
0.09
0.28
0.01
CF
0.25
0.02
0.33
DSST
0.29
0.04
0.48
TMT-B
0.31
0.01
0.28
PANSS positive and negative symptoms scale (P positive, G general, N negative), GAF global assessment of functioning, NSS neurological soft signs, COMT complex motor tasks, MOCO motor coordination, SI sensory integration, RLSPO right/left spatial orientation, HS hard signs, CF category fluency, DSST digit symbol substitution test, TMT-B trail making test part B
aValues depict the influence which an item showed on forming of a specific community. Higher values indicate higher influence

Covariate-adjusted correlation analysis

The partial correlation (C) (after log-transformation of variables that were not normally distributed) revealed that CF was significantly associated with NSS MOCO as well as NSS SI while controlling for all other variables (r = 0.25, p < 0.001 and r = − 0.33, p < 0.001, respectively; uncorrected for multiple testing). Also, TMT-B was associated with NSS SI while controlling for all other variables (r = 0.28, p < 0.001; uncorrected for multiple testing). Notably, PANSS scores were not significantly associated with NSS scores (uncorrected for multiple testing).

Discussion

Using the network approach to psychopathology, we investigated—for the first time—the interrelationship between psychopathological symptoms, sensorimotor, cognitive, and global functioning in a transdiagnostic sample consisting of SSD, MDD, and BD patients. Two main findings emerged: First, NSS showed closer connections with TMT-B, CF and DSST than with GAF and PANSS. Second, DSST, PANSS general, and NSS MOCO scores showed the highest EI, while SI, DSST, and CF showed the highest strength. However, the EGA was unstable and could not be interpreted.
The first finding supports and extends our understanding of the relationship between sensorimotor and cognitive domains for several reasons: First, there has been prior research linking more severe hypokinetic sensorimotor abnormalities (e.g., NSS and parkinsonism) to executive functioning deficiencies in SSD [52, 53]. Second, our findings are in line with Wolf et al. [54] and confirm the precise link between the sensorimotor and cognitive domains. Our findings extend this previous work transdiagnostically. Third, the TMT-B and DSST assessments are well-known tools of cognitive performance, particularly in terms of processing speed, cognitive flexibility, and the phenomenon known as psychomotor slowing. This line of reasoning suggests that a more inclusive definition of this term may incorporate sensorimotor disorders such as NSS [55]. Accordingly, Osborne et al. [55] described that the cognitive (“psycho”) and sensorimotor sub-processes that lead to psychomotor slowing may overlap with the sub-processes of subtle sensorimotor abnormalities such as NSS. Finally, NSS and TMT-B are associated with overlapping circuitry, suggesting a biological link between sensorimotor and cognitive processes [56]. On one side, changes in the inferior frontal gyrus, paracentral gyrus, inferior parietal lobe (IPL), bilateral putamen, cerebellum, and both the superior and middle temporal gyri (STG and MTG) are associated with NSS (for a summary, see also Hirjak et al. [57, 58] and Zhao et al. [59]). On the other side, the prefrontal cortex, the IPL, and the cerebellum play also a crucial role in the execution of TMT-B [60]. This implies that a shared neurobiological process may lead to manifest sensorimotor and cognitive symptoms in SSD and MOD. Our results together with the above mentioned evidence extend our current understanding of interrelated behavior in the RDoC Matrix.
Last but not least, although there have been reports—also from our group [19]—examining the bilateral link between NSS and psychopathology as well as NSS and cognition [20, 21], the precise trilateral relationship between cognition, NSS, and psychopathology remains unclear. We interpret our results as suggesting that sensorimotor symptoms are closer to cognition than psychopathology, but this relationship does not exclude connections between NSS and psychopathology. Indeed, as shown in Table 2, PANSS positive and negative subscales showed (rather weak) partial correlations with NSS subscales. Psychopathology also showed few connections with cognitive symptoms, which is in line with assumptions that the psychopathology domain by itself (as outcome parameter) only incompletely reflects functional impairment, which is more closely connected with cognitive deficits [61].
Second, the most central nodes in terms of EI were DSST, PANSS general, and NSS MOCO scores. All nodes showed a positive value in the centrality index. In terms of strength, SI, DSST and CF showed the highest centrality. These findings are crucial for a number of reasons: First, the DSST examines processing speed, working memory, visuospatial processing, and attention. Also, another recent network analysis in SSD showed a central place for processing speed evaluated with symbol coding [42]. This said, DSST reflects the global cognitive functioning, which, when impaired, can lead to disturbances at the level of sensorimotor functions. In line with this, Morrens et al. [62] used DSST (e.g., matching time and writing time) to examine sensorimotor and cognitive slowing in SSD. Although the authors concluded that both processes are unrelated, matching time was associated with neuropsychological test results. Second, this fits in well, because MOCO also plays a central role in our network. The MOCO subscale includes five items, such as Ozeretski’s test, diadochokinesia, pronation/supination, finger-to-thumb opposition, and speech articulation. Both DSST and MOCO are based on movement execution, predominantly at the level of sensorimotor and visuospatial control. Third, disturbances of sensorimotor and spatial–visual control can lead to various psychopathological symptoms, such as somatic concerns, anxiety, depression, motor retardation, disorientation, disturbance of volition, poor impulsive control, and preoccupation, respectively [63, 64]. This could be a possible explanation for the centrality of the PANSS general scores. Fourth, as proposed by the European consensus on assessments and perspectives [26], new treatment targets for stimulation techniques need to be identified. From a network point of view, variables are interrelated and targeting the most central nodes could affect other nodes as well. Consequently the connection between sensorimotor symptoms and cognition and the high centrality of sensorimotor symptoms suggest that sensorimotor symptoms and cognitive symptoms may share aspects of pathophysiology. Specifically, the high centrality of MOCO and SI together with the previously identified neurobiological correlates of NSS may suggest NSS MOCO and SI as possible treatment targets for stimulation techniques (such as transcranial direct current stimulation or repetitive transcranial magnetic stimulation) in order to improve cognition. In addition, one may wonder whether movement exercises that train the individual items of the two subscales could also lead to an improvement in cognition. This is in accordance with previous reports showing associations between NSS and cognition in longitudinal investigations [20]. Previously reported structural correlates of NSS [25] would be the primary neurobiological target regions for these stimulation techniques. This train of thought seems particularly relevant since cognitive deficits in SSD are associated with lower global and social functioning [61, 65] and are difficult to treat so far. Yet, while structural correlates of NSS have been repeatedly demonstrated in SSD [25, 6669], we are not aware of such data in BD or MDD. When interpreting our results, it is important to bear in mind that there may not be a direct link between our non-direct, non-causal network analysis and neurobiological pathophysiology.
Taken together, complex phenomena (such as cognitive, psychopathological, and sensorimotor symptoms) may be best described at the systems level [13, 7072]. More precisely, a shift from focusing on individual components to studying the organization of the system’s components seems promising [13, 7072]. Network analysis provides tools to identify a system’s components and their relationships [70]. In this context, the particular benefit of network analysis techniques may be provided by their focus on patterns of pairwise conditional relationships as well as by enabling powerful visualizations of those patterns [70]. Furthermore, previous studies have established relationships between the sensorimotor and cognitive domain [52, 53]. However, the methods applied in these studies were limited: they were not able to simultaneously take into account the dynamic effects of other relevant variables on the relationship of interest as network analysis can. Also, associations between the sensorimotor and psychopathological domains have been reported as well [19]. Yet, how these domains interact simultaneously with each other has not been investigated so far. Here, our network analysis for the first time models the interactions between the sensorimotor and cognitive domains while accounting for psychopathological symptoms and global functioning. Our results suggest that there is a closer connection between the sensorimotor and cognitive domains than between the sensorimotor and psychopathological domains. Furthermore, the reported association between the sensorimotor and cognitive domains after accounting for psychopathological symptoms and global functioning may implicate several future investigative steps: First, the close connection between the sensorimotor and cognitive domains on the level of clinical tests suggest overlapping pathophysiology between both constructs [25, 60, 73]. Longitudinal MRI studies with several network analyses sequentially excluding psychopathological symptoms and global functioning may shed more light on the precise relationship between sensorimotor and cognitive symptoms. Another road may be—in accordance with previous network analysis literature [70, 71, 74]—to consider either sensorimotor symptoms or cognitive symptoms as treatment targets and investigate the effects on both domains after pharmacological and non-pharmacological (stimulation techniques) interventions.

Strengths and limitations

The study sample size, a solid theoretical framework, and the use of two network indices, such as EI and strength centrality, are the main strengths of this study. However, this study also has limitations: First, sample size of BD and MDD subgroups was limited, which could imply that our results may have been more influenced by our SSD subgroup. Due to small group sizes in our MOD participants, we were not able to perform the network analyses in this subgroup, thus uncertainty remains whether our findings truly extend to MOD. Yet, in separate analyses including only SSD participants (n = 174), the results remained comparable. Still, the imbalance in the examined groups concerning the diagnosis could lead to sampling bias, making it difficult to generalize the findings to the broader population. Therefore, the question as to whether sensorimotor symptoms are really a transdiagnostic therapeutic target needs to be examined in future studies including larger and more balanced diagnostic groups. Second, by employing cross-sectional data, we cannot make inferences about long-term relationships between psychopathology, sensorimotor, and cognitive symptoms and we advocate longitudinal studies which could better test for causality. Third, we did not employ second-generation negative symptom scales such as the BNSS. However, our focus in this project was to analyze the entire psychopathological domain, for which PANSS remains the most widely used scale in SSD and other psychiatric disorders such as MOD (please refer to PANSS general symptoms). Fourth, we are aware of the previous network analyses [14, 15, 75, 76] which examined data on several levels ranging from total scores to sub-scores to single items level. The authors stated that more knowledge could be accumulated through the multilevel analysis. The study by Fried et al. [77] corroborate this view and performed network analyses on several levels. The authors [77] reported that relationships between depression and inflammation were strongly attenuated after controlling for BMI. They also concluded that decomposing sum scores may lead to reduced reliability [77]. Therefore, we assume that our network analysis could reveal more detailed insights if performed on several levels. However, in our study, we were interested in the interplay between psychopathology, sensorimotor, cognitive and global functioning more globally. Thus, we opted for subscores/subscales rather than single-item level scores. In addition, investigating many individual features (i.e., including more nodes in the network) makes network estimation more complex, requiring larger study groups in order to yield stable networks and consequently, we refrained from these analyses. Last but not least, our hypotheses were focused on investigations of the relationships between the different domains and not individual items.

Conclusion

This is the first study that sought to investigate the pattern of connections among a wide array of functional domains, such psychopathological symptoms, sensorimotor, cognitive, and global functioning in a transdiagnostic sample consisting SSD and MOD patients. Aspects of the pathophysiology underlying both SSD and MOD are likely shared, given the close relationship between NSS and cognitive functioning and the high centrality of sensorimotor symptoms. However, given that a significant proportion of the study participants had SSD, further research with more balanced diagnostic groups is required to determine whether sensorimotor symptoms truly represent a transdiagnostic therapeutic target.

Acknowledgements

We are grateful to all the patients and their families for their time and interest in our studies.

Declarations

Conflict of interest

The authors declare that there are no conflicts of interest in relation to the subject of this study.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Neuer Inhalt

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Anhänge

Supplementary Information

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Lange SMM, Schirmbeck F, Stek ML, Murk Jansen YR, van Rooijen G, de Haan L, Penninx B, Rhebergen D, Investigators G (2021) A comparison of depressive symptom profiles between current major depressive disorder and schizophrenia spectrum disorder. J Psychiatr Res 135:143–151PubMedCrossRef Lange SMM, Schirmbeck F, Stek ML, Murk Jansen YR, van Rooijen G, de Haan L, Penninx B, Rhebergen D, Investigators G (2021) A comparison of depressive symptom profiles between current major depressive disorder and schizophrenia spectrum disorder. J Psychiatr Res 135:143–151PubMedCrossRef
2.
Zurück zum Zitat Kanchanatawan B, Sirivichayakul S, Thika S, Ruxrungtham K, Carvalho AF, Geffard M, Anderson G, Noto C, Ivanova R, Maes M (2017) Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway. Metab Brain Dis 32:1003–1016PubMedCrossRef Kanchanatawan B, Sirivichayakul S, Thika S, Ruxrungtham K, Carvalho AF, Geffard M, Anderson G, Noto C, Ivanova R, Maes M (2017) Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway. Metab Brain Dis 32:1003–1016PubMedCrossRef
3.
Zurück zum Zitat Fritze S, Sambataro F, Kubera KM, Brandt GA, Meyer-Lindenberg A, Wolf RC, Hirjak D (2022) Characterizing the sensorimotor domain in schizophrenia spectrum disorders. Eur Arch Psychiatry Clin Neurosci 272:1097–1108PubMedCrossRef Fritze S, Sambataro F, Kubera KM, Brandt GA, Meyer-Lindenberg A, Wolf RC, Hirjak D (2022) Characterizing the sensorimotor domain in schizophrenia spectrum disorders. Eur Arch Psychiatry Clin Neurosci 272:1097–1108PubMedCrossRef
4.
Zurück zum Zitat Arias JA, Williams C, Raghvani R, Aghajani M, Baez S, Belzung C, Booij L, Busatto G, Chiarella J, Fu CH, Ibanez A, Liddell BJ, Lowe L, Penninx B, Rosa P, Kemp AH (2020) The neuroscience of sadness: a multidisciplinary synthesis and collaborative review. Neurosci Biobehav Rev 111:199–228PubMedCrossRef Arias JA, Williams C, Raghvani R, Aghajani M, Baez S, Belzung C, Booij L, Busatto G, Chiarella J, Fu CH, Ibanez A, Liddell BJ, Lowe L, Penninx B, Rosa P, Kemp AH (2020) The neuroscience of sadness: a multidisciplinary synthesis and collaborative review. Neurosci Biobehav Rev 111:199–228PubMedCrossRef
5.
Zurück zum Zitat Kovacs LN, Takacs ZK, Toth Z, Simon E, Schmelowszky A, Kokonyei G (2020) Rumination in major depressive and bipolar disorder—a meta-analysis. J Affect Disord 276:1131–1141PubMedCrossRef Kovacs LN, Takacs ZK, Toth Z, Simon E, Schmelowszky A, Kokonyei G (2020) Rumination in major depressive and bipolar disorder—a meta-analysis. J Affect Disord 276:1131–1141PubMedCrossRef
6.
Zurück zum Zitat Chen L, Wang Q, Xu T (2023) Working memory function in patients with major depression disorder: a narrative review. Clin Psychol Psychother 30:281–293PubMedCrossRef Chen L, Wang Q, Xu T (2023) Working memory function in patients with major depression disorder: a narrative review. Clin Psychol Psychother 30:281–293PubMedCrossRef
7.
Zurück zum Zitat van Eeden WA, van Hemert AM, Carlier IVE, Penninx BW, Spinhoven P, Giltay EJ (2019) Neuroticism and chronicity as predictors of 9-year course of individual depressive symptoms. J Affect Disord 252:484–492PubMedCrossRef van Eeden WA, van Hemert AM, Carlier IVE, Penninx BW, Spinhoven P, Giltay EJ (2019) Neuroticism and chronicity as predictors of 9-year course of individual depressive symptoms. J Affect Disord 252:484–492PubMedCrossRef
8.
Zurück zum Zitat Oliva V, Fanelli G, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, Kas MJ, De Ronchi D, Fabbri C, Serretti A (2022) Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts. Int Clin Psychopharmacol 37:38–45PubMedCrossRef Oliva V, Fanelli G, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, Kas MJ, De Ronchi D, Fabbri C, Serretti A (2022) Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts. Int Clin Psychopharmacol 37:38–45PubMedCrossRef
9.
Zurück zum Zitat Song XM, Hu XW, Li Z, Gao Y, Ju X, Liu DY, Wang QN, Xue C, Cai YC, Bai R, Tan ZL, Northoff G (2021) Reduction of higher-order occipital gaba and impaired visual perception in acute major depressive disorder. Mol Psychiatry 26:6747–6755PubMedPubMedCentralCrossRef Song XM, Hu XW, Li Z, Gao Y, Ju X, Liu DY, Wang QN, Xue C, Cai YC, Bai R, Tan ZL, Northoff G (2021) Reduction of higher-order occipital gaba and impaired visual perception in acute major depressive disorder. Mol Psychiatry 26:6747–6755PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Walther S, Bernard JA, Mittal VA, Shankman SA (2019) The utility of an rdoc motor domain to understand psychomotor symptoms in depression. Psychol Med 49:212–216PubMedCrossRef Walther S, Bernard JA, Mittal VA, Shankman SA (2019) The utility of an rdoc motor domain to understand psychomotor symptoms in depression. Psychol Med 49:212–216PubMedCrossRef
11.
Zurück zum Zitat Fonseca-Pedrero E (2017) Network analysis: a new way of understanding psychopathology? Rev Psiquiatr Salud Ment 10:206–215PubMedCrossRef Fonseca-Pedrero E (2017) Network analysis: a new way of understanding psychopathology? Rev Psiquiatr Salud Ment 10:206–215PubMedCrossRef
14.
Zurück zum Zitat Abplanalp SJ, Braff DL, Light GA, Nuechterlein KH, Green MF, Consortium on the Genetics of S (2022) Understanding connections and boundaries between positive symptoms, negative symptoms, and role functioning among individuals with schizophrenia: a network psychometric approach. JAMA Psychiat 79:1014–1022CrossRef Abplanalp SJ, Braff DL, Light GA, Nuechterlein KH, Green MF, Consortium on the Genetics of S (2022) Understanding connections and boundaries between positive symptoms, negative symptoms, and role functioning among individuals with schizophrenia: a network psychometric approach. JAMA Psychiat 79:1014–1022CrossRef
15.
Zurück zum Zitat Abplanalp SJ, Mueser KT, Fulford D (2022) The centrality of motivation in psychosocial functioning: network and bifactor analysis of the quality of life scale in first-episode psychosis. Psychol Assess 34:205–216PubMedCrossRef Abplanalp SJ, Mueser KT, Fulford D (2022) The centrality of motivation in psychosocial functioning: network and bifactor analysis of the quality of life scale in first-episode psychosis. Psychol Assess 34:205–216PubMedCrossRef
16.
Zurück zum Zitat Dal Santo F, Fonseca-Pedrero E, Garcia-Portilla MP, Gonzalez-Blanco L, Saiz PA, Galderisi S, Giordano GM, Bobes J (2022) Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: a network analysis from the optimise trial. Eur Psychiatry 65:e33CrossRef Dal Santo F, Fonseca-Pedrero E, Garcia-Portilla MP, Gonzalez-Blanco L, Saiz PA, Galderisi S, Giordano GM, Bobes J (2022) Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: a network analysis from the optimise trial. Eur Psychiatry 65:e33CrossRef
17.
Zurück zum Zitat Strauss GP, Esfahlani FZ, Galderisi S, Mucci A, Rossi A, Bucci P, Rocca P, Maj M, Kirkpatrick B, Ruiz I, Sayama H (2019) Network analysis reveals the latent structure of negative symptoms in schizophrenia. Schizophr Bull 45:1033–1041PubMedCrossRef Strauss GP, Esfahlani FZ, Galderisi S, Mucci A, Rossi A, Bucci P, Rocca P, Maj M, Kirkpatrick B, Ruiz I, Sayama H (2019) Network analysis reveals the latent structure of negative symptoms in schizophrenia. Schizophr Bull 45:1033–1041PubMedCrossRef
18.
Zurück zum Zitat Galderisi S, Rucci P, Kirkpatrick B, Mucci A, Gibertoni D, Rocca P, Rossi A, Bertolino A, Strauss GP, Aguglia E, Bellomo A, Murri MB, Bucci P, Carpiniello B, Comparelli A, Cuomo A, De Berardis D, Dell’Osso L, Di Fabio F, Gelao B, Marchesi C, Monteleone P, Montemagni C, Orsenigo G, Pacitti F, Roncone R, Santonastaso P, Siracusano A, Vignapiano A, Vita A, Zeppegno P, Maj M, Italian Network for Research on P (2018) Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia: a network analysis. JAMA Psychiat 75:396–404CrossRef Galderisi S, Rucci P, Kirkpatrick B, Mucci A, Gibertoni D, Rocca P, Rossi A, Bertolino A, Strauss GP, Aguglia E, Bellomo A, Murri MB, Bucci P, Carpiniello B, Comparelli A, Cuomo A, De Berardis D, Dell’Osso L, Di Fabio F, Gelao B, Marchesi C, Monteleone P, Montemagni C, Orsenigo G, Pacitti F, Roncone R, Santonastaso P, Siracusano A, Vignapiano A, Vita A, Zeppegno P, Maj M, Italian Network for Research on P (2018) Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia: a network analysis. JAMA Psychiat 75:396–404CrossRef
19.
Zurück zum Zitat Sambataro F, Fritze S, Rashidi M, Topor CE, Kubera KM, Wolf RC, Hirjak D (2020) Moving forward: distinct sensorimotor abnormalities predict clinical outcome after 6 months in patients with schizophrenia. Eur Neuropsychopharmacol 36:72–82PubMedCrossRef Sambataro F, Fritze S, Rashidi M, Topor CE, Kubera KM, Wolf RC, Hirjak D (2020) Moving forward: distinct sensorimotor abnormalities predict clinical outcome after 6 months in patients with schizophrenia. Eur Neuropsychopharmacol 36:72–82PubMedCrossRef
20.
Zurück zum Zitat Herold CJ, Duval CZ, Schröder J (2021) Neurological soft signs and cognition in the late course of chronic schizophrenia: a longitudinal study. Eur Arch Psychiatry Clin Neurosci 271:1465–1473PubMedCrossRef Herold CJ, Duval CZ, Schröder J (2021) Neurological soft signs and cognition in the late course of chronic schizophrenia: a longitudinal study. Eur Arch Psychiatry Clin Neurosci 271:1465–1473PubMedCrossRef
21.
Zurück zum Zitat Bachmann S, Schröder J (2017) Neurological soft signs in schizophrenia: an update on the state- versus trait-perspective. Front Psych 8:272CrossRef Bachmann S, Schröder J (2017) Neurological soft signs in schizophrenia: an update on the state- versus trait-perspective. Front Psych 8:272CrossRef
22.
Zurück zum Zitat Valerio MP, Lomastro J, Igoa A, Martino DJ (2023) Correlates of neurological soft signs in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 273:1183–1190PubMedCrossRef Valerio MP, Lomastro J, Igoa A, Martino DJ (2023) Correlates of neurological soft signs in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 273:1183–1190PubMedCrossRef
23.
Zurück zum Zitat Schröder J, Niethammer R, Geider FJ, Reitz C, Binkert M, Jauss M, Sauer H (1991) Neurological soft signs in schizophrenia. Schizophr Res 6:25–30PubMedCrossRef Schröder J, Niethammer R, Geider FJ, Reitz C, Binkert M, Jauss M, Sauer H (1991) Neurological soft signs in schizophrenia. Schizophr Res 6:25–30PubMedCrossRef
24.
Zurück zum Zitat Hurford IM, Marder SR, Keefe RS, Reise SP, Bilder RM (2011) A brief cognitive assessment tool for schizophrenia: construction of a tool for clinicians. Schizophr Bull 37:538–545PubMedCrossRef Hurford IM, Marder SR, Keefe RS, Reise SP, Bilder RM (2011) A brief cognitive assessment tool for schizophrenia: construction of a tool for clinicians. Schizophr Bull 37:538–545PubMedCrossRef
25.
Zurück zum Zitat Zhao Q, Li Z, Huang J, Yan C, Dazzan P, Pantelis C, Cheung EF, Lui SS, Chan RC (2014) Neurological soft signs are not “soft” in brain structure and functional networks: evidence from ale meta-analysis. Schizophr Bull 40:626–641PubMedCrossRef Zhao Q, Li Z, Huang J, Yan C, Dazzan P, Pantelis C, Cheung EF, Lui SS, Chan RC (2014) Neurological soft signs are not “soft” in brain structure and functional networks: evidence from ale meta-analysis. Schizophr Bull 40:626–641PubMedCrossRef
26.
Zurück zum Zitat Walther S, van Harten PN, Waddington JL, Cuesta MJ, Peralta V, Dupin L, Foucher JR, Sambataro F, Morrens M, Kubera KM, Pieters LE, Stegmayer K, Strik W, Wolf RC, Hirjak D (2020) Movement disorder and sensorimotor abnormalities in schizophrenia and other psychoses—European consensus on assessment and perspectives. Eur Neuropsychopharmacol 38:25–39PubMedCrossRef Walther S, van Harten PN, Waddington JL, Cuesta MJ, Peralta V, Dupin L, Foucher JR, Sambataro F, Morrens M, Kubera KM, Pieters LE, Stegmayer K, Strik W, Wolf RC, Hirjak D (2020) Movement disorder and sensorimotor abnormalities in schizophrenia and other psychoses—European consensus on assessment and perspectives. Eur Neuropsychopharmacol 38:25–39PubMedCrossRef
27.
Zurück zum Zitat Pavlidou A, Walther S (2020) Using virtual reality as a tool in the rehabilitation of movement abnormalities in schizophrenia. Front Psychol 11:607312PubMedCrossRef Pavlidou A, Walther S (2020) Using virtual reality as a tool in the rehabilitation of movement abnormalities in schizophrenia. Front Psychol 11:607312PubMedCrossRef
28.
Zurück zum Zitat Sass H, Wittchen HU, Zaudig M, IH (2003) Diagnostisches und statistisches Manual psychischer Störungen DSM-IV-TR: Textrevision. Hogrefe Verlag; Auflage: 1 (1. Januar 2003) Sass H, Wittchen HU, Zaudig M, IH (2003) Diagnostisches und statistisches Manual psychischer Störungen DSM-IV-TR: Textrevision. Hogrefe Verlag; Auflage: 1 (1. Januar 2003)
29.
Zurück zum Zitat Hirjak D, Kubera KM, Northoff G, Fritze S, Bertolino AL, Topor CE, Schmitgen MM, Wolf RC (2019) Cortical contributions to distinct symptom dimensions of catatonia. Schizophr Bull 45:1184–1194PubMedPubMedCentralCrossRef Hirjak D, Kubera KM, Northoff G, Fritze S, Bertolino AL, Topor CE, Schmitgen MM, Wolf RC (2019) Cortical contributions to distinct symptom dimensions of catatonia. Schizophr Bull 45:1184–1194PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Hirjak D, Rashidi M, Kubera KM, Northoff G, Fritze S, Schmitgen MM, Sambataro F, Calhoun VD, Wolf RC (2019) Multimodal magnetic resonance imaging data fusion reveals distinct patterns of abnormal brain structure and function in catatonia. Schizophrenia Bull 46:202–210CrossRef Hirjak D, Rashidi M, Kubera KM, Northoff G, Fritze S, Schmitgen MM, Sambataro F, Calhoun VD, Wolf RC (2019) Multimodal magnetic resonance imaging data fusion reveals distinct patterns of abnormal brain structure and function in catatonia. Schizophrenia Bull 46:202–210CrossRef
33.
Zurück zum Zitat Margraf J, Schneider S, Ehlers A, Psychologie C-D-SFK (1994) Diagnostisches interview bei psychischen störungen: dips. SpringerCrossRef Margraf J, Schneider S, Ehlers A, Psychologie C-D-SFK (1994) Diagnostisches interview bei psychischen störungen: dips. SpringerCrossRef
34.
Zurück zum Zitat Leucht S, Samara M, Heres S, Patel MX, Furukawa T, Cipriani A, Geddes J, Davis JM (2015) Dose equivalents for second-generation antipsychotic drugs: the classical mean dose method. Schizophr Bull 41:1397–1402PubMedPubMedCentralCrossRef Leucht S, Samara M, Heres S, Patel MX, Furukawa T, Cipriani A, Geddes J, Davis JM (2015) Dose equivalents for second-generation antipsychotic drugs: the classical mean dose method. Schizophr Bull 41:1397–1402PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Hayasaka Y, Purgato M, Magni LR, Ogawa Y, Takeshima N, Cipriani A, Barbui C, Leucht S, Furukawa TA (2015) Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials. J Affect Disord 180:179–184PubMedCrossRef Hayasaka Y, Purgato M, Magni LR, Ogawa Y, Takeshima N, Cipriani A, Barbui C, Leucht S, Furukawa TA (2015) Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials. J Affect Disord 180:179–184PubMedCrossRef
36.
Zurück zum Zitat Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (panss) for schizophrenia. Schizophr Bull 13:261–276PubMedCrossRef Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (panss) for schizophrenia. Schizophr Bull 13:261–276PubMedCrossRef
37.
Zurück zum Zitat Dsm-iiiR (1989) Dkudddusmpsr gaf-skala: global assessment of functioning scale. Beltz, Weinheim, Basel Dsm-iiiR (1989) Dkudddusmpsr gaf-skala: global assessment of functioning scale. Beltz, Weinheim, Basel
38.
Zurück zum Zitat Amieva H, Meillon C, Proust-Lima C, Dartigues JF (2019) Is low psychomotor speed a marker of brain vulnerability in late life? Digit symbol substitution test in the prediction of Alzheimer, Parkinson, stroke, disability, and depression. Dement Geriatr Cogn Disord 47:297–305PubMedCrossRef Amieva H, Meillon C, Proust-Lima C, Dartigues JF (2019) Is low psychomotor speed a marker of brain vulnerability in late life? Digit symbol substitution test in the prediction of Alzheimer, Parkinson, stroke, disability, and depression. Dement Geriatr Cogn Disord 47:297–305PubMedCrossRef
39.
Zurück zum Zitat Boylu ME, Turan S, Guler EM, Boylu FB, Kilic O, Kocyigit A, Kirpinar I (2023) Changes in neuroactive steroids, neurotrophins and immunological biomarkers after monotherapy 8-week rtms treatment and their relationship with neurocognitive functions in depression. Eur Arch Psychiatry Clin Neurosci. https://doi.org/10.1007/s00406-023-01704-9CrossRefPubMed Boylu ME, Turan S, Guler EM, Boylu FB, Kilic O, Kocyigit A, Kirpinar I (2023) Changes in neuroactive steroids, neurotrophins and immunological biomarkers after monotherapy 8-week rtms treatment and their relationship with neurocognitive functions in depression. Eur Arch Psychiatry Clin Neurosci. https://​doi.​org/​10.​1007/​s00406-023-01704-9CrossRefPubMed
40.
Zurück zum Zitat Nixon N, Guo B, Kaylor-Hughes C, Simpson S, Garland A, Dalgleish T, Morriss R (2024) Specialist treatment for persistent depression in secondary care: sustained effects from a multicentre UK study at 24 and 36 months. J Affect Disord 345:70–77PubMedCrossRef Nixon N, Guo B, Kaylor-Hughes C, Simpson S, Garland A, Dalgleish T, Morriss R (2024) Specialist treatment for persistent depression in secondary care: sustained effects from a multicentre UK study at 24 and 36 months. J Affect Disord 345:70–77PubMedCrossRef
42.
Zurück zum Zitat Karyakina M, Shmukler A (2021) Network analysis of cognitive deficit in patients with schizophrenia spectrum disorders. Schizophr Res Cogn 26:100213PubMedPubMedCentralCrossRef Karyakina M, Shmukler A (2021) Network analysis of cognitive deficit in patients with schizophrenia spectrum disorders. Schizophr Res Cogn 26:100213PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Strauss GP, Esfahlani FZ, Kirkpatrick B, Allen DN, Gold JM, Visser KF, Sayama H (2019) Network analysis reveals which negative symptom domains are most central in schizophrenia vs bipolar disorder. Schizophr Bull 45:1319–1330PubMedPubMedCentralCrossRef Strauss GP, Esfahlani FZ, Kirkpatrick B, Allen DN, Gold JM, Visser KF, Sayama H (2019) Network analysis reveals which negative symptom domains are most central in schizophrenia vs bipolar disorder. Schizophr Bull 45:1319–1330PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Strauss GP, Zamani Esfahlani F, Sayama H, Kirkpatrick B, Opler MG, Saoud JB, Davidson M, Luthringer R (2020) Network analysis indicates that avolition is the most central domain for the successful treatment of negative symptoms: evidence from the roluperidone randomized clinical trial. Schizophr Bull 46:964–970PubMedPubMedCentralCrossRef Strauss GP, Zamani Esfahlani F, Sayama H, Kirkpatrick B, Opler MG, Saoud JB, Davidson M, Luthringer R (2020) Network analysis indicates that avolition is the most central domain for the successful treatment of negative symptoms: evidence from the roluperidone randomized clinical trial. Schizophr Bull 46:964–970PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Costantini G, Epskamp S, Borsboom D, Perugini M, Mõttus R, Waldorp LJ, Cramer AO (2015) State of the art personality research: a tutorial on network analysis of personality data in R. J Res Pers 54:13–29CrossRef Costantini G, Epskamp S, Borsboom D, Perugini M, Mõttus R, Waldorp LJ, Cramer AO (2015) State of the art personality research: a tutorial on network analysis of personality data in R. J Res Pers 54:13–29CrossRef
47.
Zurück zum Zitat Epskamp S, Borsboom D, Fried EI (2018) Estimating psychological networks and their accuracy: a tutorial paper. Behav Res Methods 50:195–212PubMedCrossRef Epskamp S, Borsboom D, Fried EI (2018) Estimating psychological networks and their accuracy: a tutorial paper. Behav Res Methods 50:195–212PubMedCrossRef
48.
Zurück zum Zitat Epskamp S, Fried EI (2018) A tutorial on regularized partial correlation networks. Psychol Methods 23:617–634PubMedCrossRef Epskamp S, Fried EI (2018) A tutorial on regularized partial correlation networks. Psychol Methods 23:617–634PubMedCrossRef
49.
Zurück zum Zitat Christensen AP, Golino H (2021) Estimating the stability of psychological dimensions via bootstrap exploratory graph analysis: a Monte Carlo simulation and tutorial. Psych 3:479–500CrossRef Christensen AP, Golino H (2021) Estimating the stability of psychological dimensions via bootstrap exploratory graph analysis: a Monte Carlo simulation and tutorial. Psych 3:479–500CrossRef
50.
Zurück zum Zitat Golino H, Shi D, Christensen AP (2020) Investigating the performance of exploratory graph analysis and traditional techniques to identify the number of latent factors: a simulation and tutorial. Psychol Methods 25:292–320PubMedPubMedCentralCrossRef Golino H, Shi D, Christensen AP (2020) Investigating the performance of exploratory graph analysis and traditional techniques to identify the number of latent factors: a simulation and tutorial. Psychol Methods 25:292–320PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Golino HF, Epskamp S (2017) Exploratory graph analysis: a new approach for estimating the number of dimensions in psychological research. PLoS ONE 12:e0174035PubMedPubMedCentralCrossRef Golino HF, Epskamp S (2017) Exploratory graph analysis: a new approach for estimating the number of dimensions in psychological research. PLoS ONE 12:e0174035PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Cuesta MJ, Sánchez-Torres AM, de Jalón EG, Campos MS, Ibáñez B, Moreno-Izco L, Peralta V (2014) Spontaneous parkinsonism is associated with cognitive impairment in antipsychotic-naive patients with first-episode psychosis: a 6-month follow-up study. Schizophr Bull 40:1164–1173PubMedCrossRef Cuesta MJ, Sánchez-Torres AM, de Jalón EG, Campos MS, Ibáñez B, Moreno-Izco L, Peralta V (2014) Spontaneous parkinsonism is associated with cognitive impairment in antipsychotic-naive patients with first-episode psychosis: a 6-month follow-up study. Schizophr Bull 40:1164–1173PubMedCrossRef
53.
Zurück zum Zitat Peralta V, Basterra V, Campos MS, de Jalón EG, Moreno-Izco L, Cuesta MJ (2012) Characterization of spontaneous Parkinsonism in drug-naive patients with non-affective psychotic disorders. Eur Arch Psychiatry Clin Neurosci 262:131–138PubMedCrossRef Peralta V, Basterra V, Campos MS, de Jalón EG, Moreno-Izco L, Cuesta MJ (2012) Characterization of spontaneous Parkinsonism in drug-naive patients with non-affective psychotic disorders. Eur Arch Psychiatry Clin Neurosci 262:131–138PubMedCrossRef
54.
Zurück zum Zitat Wolf RC, Rashidi M, Schmitgen MM, Fritze S, Sambataro F, Kubera KM, Hirjak D (2021) Neurological soft signs predict auditory verbal hallucinations in patients with schizophrenia. Schizophr Bull 47:433–443PubMedCrossRef Wolf RC, Rashidi M, Schmitgen MM, Fritze S, Sambataro F, Kubera KM, Hirjak D (2021) Neurological soft signs predict auditory verbal hallucinations in patients with schizophrenia. Schizophr Bull 47:433–443PubMedCrossRef
55.
Zurück zum Zitat Osborne KJ, Walther S, Shankman SA, Mittal VA (2020) Psychomotor slowing in schizophrenia: implications for endophenotype and biomarker development. Biomark Neuropsychiatry 2:100016PubMedPubMedCentralCrossRef Osborne KJ, Walther S, Shankman SA, Mittal VA (2020) Psychomotor slowing in schizophrenia: implications for endophenotype and biomarker development. Biomark Neuropsychiatry 2:100016PubMedPubMedCentralCrossRef
56.
Zurück zum Zitat Gay O, Plaze M, Oppenheim C, Gaillard R, Olie JP, Krebs MO, Cachia A (2016) Cognitive control deficit in patients with first-episode schizophrenia is associated with complex deviations of early brain development. J Psychiatry Neurosci 41:150267PubMed Gay O, Plaze M, Oppenheim C, Gaillard R, Olie JP, Krebs MO, Cachia A (2016) Cognitive control deficit in patients with first-episode schizophrenia is associated with complex deviations of early brain development. J Psychiatry Neurosci 41:150267PubMed
57.
Zurück zum Zitat Hirjak D, Meyer-Lindenberg A, Kubera KM, Thomann PA, Wolf RC (2018) Motor dysfunction as research domain in the period preceding manifest schizophrenia: a systematic review. Neurosci Biobehav Rev 87:87–105PubMedCrossRef Hirjak D, Meyer-Lindenberg A, Kubera KM, Thomann PA, Wolf RC (2018) Motor dysfunction as research domain in the period preceding manifest schizophrenia: a systematic review. Neurosci Biobehav Rev 87:87–105PubMedCrossRef
58.
Zurück zum Zitat Hirjak D, Thomann PA, Kubera KM, Wolf ND, Sambataro F, Wolf RC (2015) Motor dysfunction within the schizophrenia-spectrum: a dimensional step towards an underappreciated domain. Schizophr Res 169:217–233PubMedCrossRef Hirjak D, Thomann PA, Kubera KM, Wolf ND, Sambataro F, Wolf RC (2015) Motor dysfunction within the schizophrenia-spectrum: a dimensional step towards an underappreciated domain. Schizophr Res 169:217–233PubMedCrossRef
59.
Zurück zum Zitat Zhao Q, Li Z, Huang J, Yan C, Dazzan P, Pantelis C, Cheung EF, Lui SS, Chan RC (2013) Neurological soft signs are not “soft” in brain structure and functional networks: evidence from ale meta-analysis. Schizophr Bull 40:626–641PubMedPubMedCentralCrossRef Zhao Q, Li Z, Huang J, Yan C, Dazzan P, Pantelis C, Cheung EF, Lui SS, Chan RC (2013) Neurological soft signs are not “soft” in brain structure and functional networks: evidence from ale meta-analysis. Schizophr Bull 40:626–641PubMedPubMedCentralCrossRef
60.
Zurück zum Zitat Rusch N, Spoletini I, Wilke M, Bria P, Di Paola M, Di Iulio F, Martinotti G, Caltagirone C, Spalletta G (2007) Prefrontal-thalamic-cerebellar gray matter networks and executive functioning in schizophrenia. Schizophr Res 93:79–89PubMedCrossRef Rusch N, Spoletini I, Wilke M, Bria P, Di Paola M, Di Iulio F, Martinotti G, Caltagirone C, Spalletta G (2007) Prefrontal-thalamic-cerebellar gray matter networks and executive functioning in schizophrenia. Schizophr Res 93:79–89PubMedCrossRef
61.
Zurück zum Zitat Owen MJ, Sawa A, Mortensen PB (2016) Schizophrenia. Lancet (Lond, Engl) 388:86–97CrossRef Owen MJ, Sawa A, Mortensen PB (2016) Schizophrenia. Lancet (Lond, Engl) 388:86–97CrossRef
62.
Zurück zum Zitat Morrens M, Hulstijn W, Van Hecke J, Peuskens J, Sabbe BG (2006) Sensorimotor and cognitive slowing in schizophrenia as measured by the symbol digit substitution test. J Psychiatr Res 40:200–206PubMedCrossRef Morrens M, Hulstijn W, Van Hecke J, Peuskens J, Sabbe BG (2006) Sensorimotor and cognitive slowing in schizophrenia as measured by the symbol digit substitution test. J Psychiatr Res 40:200–206PubMedCrossRef
63.
Zurück zum Zitat Velasques B, Machado S, Paes F, Cunha M, Sanfim A, Budde H, Cagy M, Anghinah R, Basile LF, Piedade R, Ribeiro P (2011) Sensorimotor integration and psychopathology: motor control abnormalities related to psychiatric disorders. World J Biol Psychiatry 12(8):560–573. https://doi.org/10.3109/15622975.2010.551405 Velasques B, Machado S, Paes F, Cunha M, Sanfim A, Budde H, Cagy M, Anghinah R, Basile LF, Piedade R, Ribeiro P (2011) Sensorimotor integration and psychopathology: motor control abnormalities related to psychiatric disorders. World J Biol Psychiatry 12(8):560–573. https://​doi.​org/​10.​3109/​15622975.​2010.​551405
65.
Zurück zum Zitat Kharawala S, Hastedt C, Podhorna J, Shukla H, Kappelhoff B, Harvey PD (2022) The relationship between cognition and functioning in schizophrenia: a semi-systematic review. Schizophr Res Cogn 27:100217PubMedCrossRef Kharawala S, Hastedt C, Podhorna J, Shukla H, Kappelhoff B, Harvey PD (2022) The relationship between cognition and functioning in schizophrenia: a semi-systematic review. Schizophr Res Cogn 27:100217PubMedCrossRef
66.
Zurück zum Zitat Hirjak D, Wolf RC, Paternoga I, Kubera KM, Thomann AK, Stieltjes B, Maier-Hein KH, Thomann PA (2016) Neuroanatomical markers of neurological soft signs in recent-onset schizophrenia and asperger-syndrome. Brain Topogr 29(3):382–394. https://doi.org/10.1007/s10548-015-0468-9 Hirjak D, Wolf RC, Paternoga I, Kubera KM, Thomann AK, Stieltjes B, Maier-Hein KH, Thomann PA (2016) Neuroanatomical markers of neurological soft signs in recent-onset schizophrenia and asperger-syndrome. Brain Topogr 29(3):382–394. https://​doi.​org/​10.​1007/​s10548-015-0468-9
68.
Zurück zum Zitat Hirjak D, Rashidi M, Fritze S, Bertolino AL, Geiger LS, Zang Z, Kubera KM, Schmitgen MM, Sambataro F, Calhoun VD, Weisbrod M, Tost H, Wolf RC (2019) Patterns of co-altered brain structure and function underlying neurological soft signs in schizophrenia spectrum disorders. Hum Brain Mapp 40(17):5029–5041. https://doi.org/10.1002/hbm.24755 Hirjak D, Rashidi M, Fritze S, Bertolino AL, Geiger LS, Zang Z, Kubera KM, Schmitgen MM, Sambataro F, Calhoun VD, Weisbrod M, Tost H, Wolf RC (2019) Patterns of co-altered brain structure and function underlying neurological soft signs in schizophrenia spectrum disorders. Hum Brain Mapp 40(17):5029–5041. https://​doi.​org/​10.​1002/​hbm.​24755
69.
70.
Zurück zum Zitat Borsboom D, Deserno MK, Rhemtulla M, Epskamp S, Fried EI, McNally RJ, Robinaugh DJ, Perugini M, Dalege J, Costantini G (2021) Network analysis of multivariate data in psychological science. Nat Rev Methods Primers 1:58CrossRef Borsboom D, Deserno MK, Rhemtulla M, Epskamp S, Fried EI, McNally RJ, Robinaugh DJ, Perugini M, Dalege J, Costantini G (2021) Network analysis of multivariate data in psychological science. Nat Rev Methods Primers 1:58CrossRef
71.
72.
73.
Zurück zum Zitat Gay O, Plaze M, Oppenheim C, Gaillard R, Olie JP, Krebs MO, Cachia A (2017) Cognitive control deficit in patients with first-episode schizophrenia is associated with complex deviations of early brain development. J Psychiatry Neurosci 42:87–94PubMedCrossRef Gay O, Plaze M, Oppenheim C, Gaillard R, Olie JP, Krebs MO, Cachia A (2017) Cognitive control deficit in patients with first-episode schizophrenia is associated with complex deviations of early brain development. J Psychiatry Neurosci 42:87–94PubMedCrossRef
74.
Zurück zum Zitat Elliott H, Jones PJ, Schmidt U (2020) Central symptoms predict posttreatment outcomes and clinical impairment in anorexia nervosa: a network analysis. Clin Psychol Sci 8:139–154CrossRef Elliott H, Jones PJ, Schmidt U (2020) Central symptoms predict posttreatment outcomes and clinical impairment in anorexia nervosa: a network analysis. Clin Psychol Sci 8:139–154CrossRef
75.
Zurück zum Zitat Abplanalp SJ, Lee J, Horan WP, Kern RS, Penn DL, Green MF (2023) A bayesian network approach to social and nonsocial cognition in schizophrenia: are some domains more fundamental than others? Schizophr Bull 49:997–1006PubMedPubMedCentralCrossRef Abplanalp SJ, Lee J, Horan WP, Kern RS, Penn DL, Green MF (2023) A bayesian network approach to social and nonsocial cognition in schizophrenia: are some domains more fundamental than others? Schizophr Bull 49:997–1006PubMedPubMedCentralCrossRef
76.
Zurück zum Zitat Abplanalp SJ, Green MF (2022) Symptom structure in schizophrenia: implications of latent variable modeling vs network analysis. Schizophr Bull 48:538–543PubMedPubMedCentralCrossRef Abplanalp SJ, Green MF (2022) Symptom structure in schizophrenia: implications of latent variable modeling vs network analysis. Schizophr Bull 48:538–543PubMedPubMedCentralCrossRef
77.
Zurück zum Zitat Fried EI, von Stockert S, Haslbeck JMB, Lamers F, Schoevers RA, Penninx B (2020) Using network analysis to examine links between individual depressive symptoms, inflammatory markers, and covariates. Psychol Med 50:2682–2690PubMedCrossRef Fried EI, von Stockert S, Haslbeck JMB, Lamers F, Schoevers RA, Penninx B (2020) Using network analysis to examine links between individual depressive symptoms, inflammatory markers, and covariates. Psychol Med 50:2682–2690PubMedCrossRef
Metadaten
Titel
Deciphering the interplay between psychopathological symptoms, sensorimotor, cognitive and global functioning: a transdiagnostic network analysis
verfasst von
Stefan Fritze
Geva A. Brandt
Sebastian Volkmer
Jonas Daub
Maria Krayem
Jacqueline Kukovic
Emanuel Schwarz
Urs Braun
Georg Northoff
Robert Christian Wolf
Katharina M. Kubera
Andreas Meyer-Lindenberg
Dusan Hirjak
Publikationsdatum
20.03.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-024-01782-3

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.